ARHGAP26-IT1: A Drug Target / Disease Biomarker (G100874372)

Target Name: ARHGAP26-IT1

NCBI ID: G100874372

Other Name(s): ARHGAP26 intronic transcript 1

ARHGAP26-IT1: A Drug Target / Disease Biomarker

ARHGAP26-IT1 is a protein that is expressed in various tissues throughout the body. It is a part of the actinin protein family, which is known for their role in cell signaling and cytoskeletal organization. While ARHGAP26-IT1 is not a well-studied protein in its own right, its potential role in disease has been identified through its expression in several diseases, including cancer.

One of the key features of ARHGAP26-IT1 is its ability to interact with other proteins, particularly with the protein known as p16INK4a. This interaction has led some researchers to investigate the role of ARHGAP26-IT1 in the regulation of cell growth and the development of cancer.

Additionally, ARHGAP26-IT1 has been shown to play a role in the regulation of cell death, which is a critical aspect of the immune system's response to cancer. In fact, studies have shown that ARHGAP26-IT1 is involved in the regulation of apoptosis, which is the process by which cells undergo and die.

Another potential function of ARHGAP26-IT1 is its role in the regulation of inflammation. Inflammation is a critical aspect of the immune system's response to infection, and it can lead to a range of diseases, including cancer.

While more research is needed to fully understand the role of ARHGAP26-IT1 in disease, its potential as a drug target is already being investigated. Studies have shown that ARHGAP26-IT1 can be targeted with small molecules, which could lead to new treatments for a range of diseases.

In conclusion, ARHGAP26-IT1 is a protein that has the potential to be a drug target or biomarker for a range of diseases. Further research is needed to fully understand its role in disease and to develop new treatments based on its properties.

Protein Name: ARHGAP26 Intronic Transcript 1

More Common Targets